Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings

Andrea Jane Curtis, Catherine Marshall, Tim Denis Spelman, Jane Greig, Julian Elliott, Leslie Shanks, Philipp Du Cros, Esther C Casas, Marcio Silveria Da Fonseca, Daniel O'Brien

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)


The incidence of WHO stage 3 and 4 conditions during the early period after ART initiation in RLS is high, but greatly reduces over time. This is likely due to both the benefits of ART and deaths of the sickest patients occurring shortly after ART initiation. Access to appropriate disease prevention tools prior to ART, and early initiation of ART, are important for their prevention.
Original languageEnglish
Article numbere52019
Number of pages9
JournalPLoS ONE
Issue number12
Publication statusPublished - 2012

Cite this